Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Alejandro Moro Soria in Cancer Treatment
Introduction
Alejandro Moro Soria, an accomplished inventor located in Ciudad de la Habana, Cuba, has made significant strides in the field of molecular pharmacology. With a focus on developing peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors, his work is paving the way for new therapeutic strategies.
Latest Patents
Alejandro has been granted one patent titled "Peptides for the treatment of cancer associated with the human papilloma virus (HPV) and other epithelial tumors." This invention emphasizes the characterization of peptides that specifically target and block the Casein Kinase II (CKII) phosphorylation domain through direct interaction. The research showcases eleven cyclic peptides exhibiting various amino acid sequences that not only inhibit CKII phosphorylation in vitro but also show cytotoxic effects on HPV-16 transformed cells (CaSki). Furthermore, these peptides enhance the sensitivity of these cells to the cytostatic effects of interferon (IFN).
Career Highlights
Working at the Centro de Ingeniería Genética y Biotecnología, Alejandro has demonstrated an unwavering commitment to advancing medical science. His pioneering research has contributed to a deeper understanding of peptide interactions and their potential therapeutic applications in treating HPV-related cancer, making him a notable figure in the field.
Collaborations
Alejandro's innovative journey has been enriched by collaborations with skilled professionals like Silvio Ernesto Perea Rodriquez and Osvaldo Reyes Acosta. These partnerships reflect a collaborative approach towards tackling one of the pressing challenges in modern medicine — the treatment of HPV-related cancers and epithelial tumors.
Conclusion
Alejandro Moro Soria stands out as a visionary inventor who is contributing to the ongoing fight against cancer through his innovative peptide research. His patented work not only showcases his dedication to scientific excellence but also opens new avenues for treatment strategies aimed at improving patient outcomes in the battle against cancer.